🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and immunogenicity of I...
Status
Completed
Location
Incheon St. Mary's Hospital, The Catholic University of Korea etc, Total 10 hospitals.
Start Date
2012-11
Trial ID
NCT02154308
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
To evaluate the safety of a single intramuscular (IM) injection of trivalen...
Status
Completed
Location
University Hospital Ghent Center for Vaccinology
Start Date
2012-07
Trial ID
NCT01651104
Treatments Being Tested
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037
Start Date
2025-02-12
Trial ID
NCT06834347
Treatments Being Tested
This study investigates the efficacy and safety of Sodium Hyaluronate gel c...
Status
Active Not Recruiting
Location
Souad Kafafi University Hospital (SKUH), faculty of medicine, Misr University for Science and Technology (MUST)
Start Date
2025-06-20
Trial ID
NCT06999993
Treatments Being Tested
The purpose of this study is to compare the PK of single dose of vedolizuma...
Status
Completed
Location
Celerion
Start Date
2018-02-21
Trial ID
NCT03948581
Treatments Being Tested
Phase 3 study to evaluate the efficacy and safety of a benralizumab in pati...
Status
Completed
Location
Research Site
Start Date
2019-08-26
Trial ID
NCT04053634
Treatments Being Tested
This is a randomized, multicenter, double-blind, Phase 3 study with 2 paral...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-05-08
Trial ID
NCT07484230
Treatments Being Tested
The purpose of this study is to evaluate the PK and safety of ublituximab S...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2026-04-01
Trial ID
NCT07503873
Treatments Being Tested
The purpose of this study is to complement Study CBYL719C2301 (SOLAR-1) and...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2021-12-17
Trial ID
NCT05038735
Treatments Being Tested